Univest
Univest
  • Markets

Ind-Swift Laboratories (INDSWFTLAB) Share Price Touches 52-Week High of Rs 424.15

  • September 8, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Ind-Swift Laboratories Share Price
Ind-Swift Laboratories Ltd. (INDSWFTLAB) share price reached a fresh 52-week high of Rs 424.15 today and later stood at Rs 406.65, up 7.17% from the previous close. Market cap was Rs 3,253.91 crore.

Ind-Swift Laboratories Share Price was at Rs 406.65 at 3:07 PM IST on 29 October 2026, up Rs 27.20 or 7.17% from the previous close of Rs 379.45. The pharmaceutical stock touched a fresh 52-week high of Rs 424.15 during the session, and its market capitalisation stands at Rs 3,253.91 crore.

This Ind-Swift Laboratories Ltd. (INDSWFTLAB) stock update covers price action, fundamental analysis, sector benchmarks and peer comparison drawn from the latest Univest figures. The stock trades at a P/E ratio of 58.49 and a P/B ratio of 2.34, while ROE stands at 3.47% and ROCE at 4.00%. Readers following Ind-Swift Laboratories Share Price Today can use the sections below to see what the numbers show and which metrics are worth monitoring next.

Table of Contents

Toggle
  • Ind-Swift Laboratories Share Price Today: Price Action Analysis
  • Why Ind-Swift Laboratories Ltd. (INDSWFTLAB) May Be Moving Today
  • Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Ind-Swift Laboratories
  • About Ind-Swift Laboratories
  • Frequently Asked Questions
    • What is Ind-Swift Laboratories Share Price today?
    • What is the Ind-Swift Laboratories 52 week high?
    • What is the Ind-Swift Laboratories market cap?
    • What is the P/E ratio of Ind-Swift Laboratories?
    • What are the ROE and ROCE of Ind-Swift Laboratories?
    • What are the EPS and book value of Ind-Swift Laboratories?
    • Does Ind-Swift Laboratories pay a dividend?
    • Which peers are compared with Ind-Swift Laboratories?
  • Track Ind-Swift Laboratories Share Price on Univest

Ind-Swift Laboratories Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 406.65
Previous Close Rs 379.45
Today's Move +Rs 27.2 (+7.17%)
Open Rs 380
High Rs 424.15
Low Rs 373.9
Market Capitalisation Rs 3,253.91 crore

Ind-Swift Laboratories Ltd. (INDSWFTLAB) traded at Rs 406.65 versus the previous close of Rs 379.45, a rise of 7.17%. The stock opened at Rs 380, reached a high of Rs 424.15 and touched a low of Rs 373.9.

Ind-Swift Laboratories Share Price Today reflects a sharp gain: the stock is at Rs 406.65, up 7.17%, after touching a fresh 52-week high of Rs 424.15. The current price is Rs 17.50 below that one-year high, so the stock has eased back from its peak but still sits well above the previous close of Rs 379.45.

The session opened at Rs 380.00, slightly above the previous close, and the day low was Rs 373.90. From that low to the 52-week high of Rs 424.15, the stock moved across a range of Rs 50.25 within a single session. The day change of Rs 27.20 is the figure behind the 7.17% gain.

The Ind-Swift Laboratories 52 Week High marks the highest price touched by the stock in the past year. All figures are as of 29 October 2026 at 3:07 PM IST and can change before the session ends. The next step is to see whether the fundamentals and valuation behind Ind-Swift Laboratories Share Price support the move.

Why Ind-Swift Laboratories Ltd. (INDSWFTLAB) May Be Moving Today

According to recent news reports, two items were published on 29 October for INDSWFTLAB. At 3:01 pm, one report said Q2 EBITDA rose to 455 million rupees from 75 million rupees a year earlier, with the EBITDA margin widening to 18.9% from 4.7%. At 3:00 pm, a second report said Q2 net profit reached 342 million rupees, compared with 80 million rupees in the same period last year. Both reports describe sharply higher profitability year on year. These items may be connected to the move in the stock today, but the market data itself does not establish a single confirmed cause.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis

Metric Value
Market Capitalisation Rs 3,253.91 crore
P/E Ratio 58.49x
P/B Ratio 2.34x
ROE 3.47%
ROCE 4%
EPS Rs 6.49
Book Value Per Share Rs 162.43
Dividend Yield 0%

Ind-Swift Laboratories Ltd. (INDSWFTLAB) fundamental metrics show P/E 58.49x, P/B 2.34x, ROE 3.47%, ROCE 4%. These ratios show where the company stands today and are not a call to buy or sell.

Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3,253.91 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 58.49x, P/B at 2.34x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.47% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.49, book value per share of Rs 162.43, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.53x, median ROE of 11.23%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 58.49x
Benchmark Median P/E 31.53x
Benchmark Average P/E 46.15x
Benchmark P/E Range 3.21x to 598.47x
Company P/B Ratio 2.34x
Benchmark Median P/B 2.75x
Company ROE 3.47%
Benchmark Median ROE 11.23%
Company ROCE 4%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 3,253.91 crore
Benchmark Median Market Cap Rs 711.9 crore

Ind-Swift Laboratories Ltd. (INDSWFTLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 58.49x, which is above the benchmark median of 31.53x, a difference of +85.51%. A P/E difference of this kind is a reference point rather than a recommendation.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROE of 3.47%, which is below the benchmark median of 11.23%, a difference of -69.1%. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROCE of 4%, which is below the benchmark median of 13.1%, a difference of -69.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Unichem Laboratories Ltd. UNICHEMLAB 3,394.97 11.24 1.24 9.81 10.68
Solara Active Pharma Sciences Ltd. SOLARA 3,068.05 85.36 2.2 -0.63 4.61
Advanced Enzyme Technologies Ltd. ADVENZYMES 2,905.78 17.54 1.75 11.43 15.27
Aarti Drugs Ltd. AARTIDRUGS 3,681.83 21.37 2.56 13.36 12.04
Kwality Pharmaceuticals Ltd. KPL 3,742.07 47.23 10.74 22.67 24.01

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 58.49x compared with the displayed peer median of 21.37x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.47% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 12.04%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a market capitalisation of Rs 3,253.91 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Ind-Swift Laboratories

  • Ind-Swift Laboratories Share Price is up 7.17% at Rs 406.65 against a previous close of Rs 379.45.
  • The stock touched a fresh 52-week high of Rs 424.15 on 29 October 2026.
  • The P/E ratio of 58.49 is above the same-industry median of 31.53.
  • ROE of 3.47% and ROCE of 4.00% are below the industry medians of 11.23% and 13.10%.
  • Market capitalisation of Rs 3,253.91 crore is above the industry median of Rs 711.90 crore.

About Ind-Swift Laboratories

Ind-Swift Laboratories Ltd. is listed under the symbol INDSWFTLAB and operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry. Univest benchmarks it against 198 companies in the same industry, including Unichem Laboratories and Aarti Drugs.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is Ind-Swift Laboratories Share Price today?

Ans. Ind-Swift Laboratories Share Price was Rs 406.65 at 3:07 PM IST on 29 October 2026, up Rs 27.20 or 7.17% from the previous close of Rs 379.45, according to latest Univest data.

What is the Ind-Swift Laboratories 52 week high?

Ans. The stock touched a fresh 52-week high of Rs 424.15 today. The current price of Rs 406.65 is Rs 17.50 below that peak, and the day low so far is Rs 373.90 on the Ind-Swift Laboratories Share Price chart.

What is the Ind-Swift Laboratories market cap?

Ans. Ind-Swift Laboratories Market Cap is Rs 3,253.91 crore. Market capitalisation shows company size, not quality, and the median for the same Pharmaceuticals & Drugs industry benchmark is Rs 711.90 crore.

What is the P/E ratio of Ind-Swift Laboratories?

Ans. The P/E ratio is 58.49 against a same-industry median of 31.53 and an average of 46.15. That places the Ind-Swift Laboratories P/E 85.51% above the median across 169 companies with a P/E value.

What are the ROE and ROCE of Ind-Swift Laboratories?

Ans. ROE is 3.47% and ROCE is 4.00%. The industry medians are 11.23% and 13.10%, so both ratios sit below the benchmark, by 69.10% and 69.47% respectively, according to the latest Univest figures.

What are the EPS and book value of Ind-Swift Laboratories?

Ans. EPS is Rs 6.49 and book value per share is Rs 162.43. The P/B ratio of 2.34 compares with an industry median of 2.75, so it sits 14.91% below the median.

Does Ind-Swift Laboratories pay a dividend?

Ans. Dividend yield is 0%, so the latest Univest figures show no historical payout relative to the current price. Dividend yield is historical data and is not a promise of future payouts.

Which peers are compared with Ind-Swift Laboratories?

Ans. Five listed peers are compared: Unichem Laboratories, Solara Active Pharma Sciences, Advanced Enzyme Technologies, Aarti Drugs and Kwality Pharmaceuticals. Their P/E ratios range from 11.24 to 85.36 against 58.49 for Ind-Swift Laboratories.

Track Ind-Swift Laboratories Share Price on Univest

Use Ind-Swift Laboratories Ltd. (INDSWFTLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Users can follow the live Ind-Swift Laboratories Share Price on Univest, along with fundamental ratios, 52-week levels and market insights for the stock. Univest also helps users compare the company with sector peers and revisit the Ind-Swift Laboratories Share Price Update as the session progresses.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply